Total Payments
$11,541
2024 Payments
$689.67
Companies
27
Transactions
157
Medicare Patients
3,802
Medicare Billing
$503,169
Payment Breakdown by Category
Other$8,411 (72.9%)
Food & Beverage$2,724 (23.6%)
Travel$348.74 (3.0%)
Education$57.80 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,411 | 3 | 72.9% |
| Food and Beverage | $2,724 | 149 | 23.6% |
| Travel and Lodging | $348.74 | 4 | 3.0% |
| Education | $57.80 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| IDORSIA PHARMACEUTICALS US INC | $9,003 | 18 | $0 (2023) |
| Novo Nordisk Inc | $701.75 | 67 | $0 (2024) |
| Amgen Inc. | $262.32 | 12 | $0 (2024) |
| PFIZER INC. | $222.71 | 11 | $0 (2020) |
| Lilly USA, LLC | $217.41 | 9 | $0 (2024) |
| Amarin Pharma Inc. | $202.07 | 3 | $0 (2021) |
| Abbott Laboratories | $124.96 | 1 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $121.75 | 1 | $0 (2024) |
| Baxter Healthcare | $100.18 | 3 | $0 (2024) |
| Relypsa, Inc. | $95.68 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $689.67 | 29 | Novo Nordisk Inc ($141.70) |
| 2023 | $9,277 | 33 | IDORSIA PHARMACEUTICALS US INC ($9,003) |
| 2022 | $119.02 | 3 | Lilly USA, LLC ($77.11) |
| 2021 | $279.03 | 8 | Abbott Laboratories ($124.96) |
| 2020 | $346.02 | 22 | Novo Nordisk Inc ($128.99) |
| 2019 | $457.09 | 28 | Novo Nordisk Inc ($134.91) |
| 2018 | $152.28 | 19 | Novo Nordisk Inc ($124.72) |
| 2017 | $220.96 | 15 | Relypsa, Inc. ($95.68) |
All Payment Transactions
157 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Biological | ||||||
| 09/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $33.94 | General |
| Category: Immunology | ||||||
| 09/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Obesity | ||||||
| 08/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Oncology | ||||||
| 07/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Diabetes | ||||||
| 07/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Obesity | ||||||
| 06/18/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Diabetes | ||||||
| 05/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.68 | General |
| Category: Diabetes | ||||||
| 05/22/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Diabetes | ||||||
| 05/02/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Oncology | ||||||
| 04/16/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $34.20 | General |
| Category: Airway Clearance Device | ||||||
| 04/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Obesity | ||||||
| 04/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $10.29 | General |
| Category: Diabetes | ||||||
| 03/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Diabetes | ||||||
| 03/06/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $47.41 | General |
| Category: Airway Clearance Device | ||||||
| 02/28/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $121.75 | General |
| Category: Immunology | ||||||
| 02/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: Diabetes | ||||||
| 02/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Inflammation | ||||||
| 02/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,050 | 2,290 | $353,235 | $149,905 |
| 2022 | 12 | 889 | 2,174 | $301,791 | $121,997 |
| 2021 | 12 | 907 | 2,454 | $340,389 | $133,689 |
| 2020 | 12 | 956 | 2,171 | $291,380 | $97,579 |
Total Patients
3,802
Total Services
9,089
Medicare Billing
$503,169
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 275 | 709 | $98,551 | $38,842 | 39.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 200 | 384 | $78,336 | $29,878 | 38.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 112 | 469 | $63,784 | $28,393 | 44.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 192 | 192 | $42,240 | $23,727 | 56.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 77 | 93 | $24,180 | $9,157 | 37.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 32 | 42 | $18,438 | $8,801 | 47.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 39 | 47 | $9,494 | $4,115 | 43.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 17 | 19 | $5,909 | $2,959 | 50.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $3,756 | $1,901 | 50.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 34 | 83 | $4,067 | $766.48 | 18.8% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 20 | 20 | $1,000 | $634.40 | 63.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 20 | 20 | $1,000 | $590.20 | 59.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 20 | 200 | $2,480 | $141.29 | 5.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 266 | 735 | $102,095 | $41,052 | 40.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 248 | 487 | $99,246 | $37,399 | 37.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 22 | 345 | $46,920 | $18,748 | 40.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 86 | 86 | $18,920 | $10,744 | 56.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 18 | 18 | $7,902 | $3,847 | 48.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 21 | 31 | $8,060 | $3,190 | 39.6% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 68 | 68 | $3,400 | $2,038 | 59.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 68 | 68 | $3,400 | $1,930 | 56.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 20 | 23 | $4,646 | $1,851 | 39.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 39 | 103 | $5,047 | $991.15 | 19.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 22 | 199 | $1,990 | $168.88 | 8.5% |
| 81002 | Urinalysis, manual test | Office | 2022 | 11 | 11 | $165.00 | $38.12 | 23.1% |
About Dr. Peter Nguyen, M.D
Dr. Peter Nguyen, M.D is a Public Health & General Preventive Medicine healthcare provider based in Victoria, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902976483.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Nguyen, M.D has received a total of $11,541 in payments from pharmaceutical and medical device companies, with $689.67 received in 2024. These payments were reported across 157 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($8,411).
As a Medicare-enrolled provider, Nguyen has provided services to 3,802 Medicare beneficiaries, totaling 9,089 services with total Medicare billing of $503,169. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Public Health & General Preventive Medicine
- Other Specialties Internal Medicine
- Location Victoria, TX
- Active Since 11/09/2006
- Last Updated 11/19/2024
- Taxonomy Code 2083P0901X
- Entity Type Individual
- NPI Number 1902976483
Products in Payments
- QUVIVIQ (Drug) $9,003
- Ozempic (Drug) $325.05
- MOUNJARO (Drug) $217.41
- Vascepa (Drug) $202.07
- Otezla (Drug) $157.83
- Wegovy (Drug) $144.65
- Tresiba (Drug) $142.48
- HeartMate 3 Left Ventricular Assist Device (Device) $124.96
- Sotyktu (Drug) $121.75
- Hillrom - Vest System Model 105 Home Care (Device) $100.18
- Veltassa (Drug) $95.68
- EUCRISA (Drug) $79.69
- ELIQUIS (Drug) $73.47
- INTELLIS (Device) $69.13
- Repatha (Biological) $64.44
- Uloric (Drug) $63.59
- Auvelity (Drug) $63.18
- COLOGUARD (Device) $57.85
- Rybelsus (Drug) $53.28
- Aimovig (Biological) $40.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.